Industry association · Medical assistance in dying clinicians
CAMAP: the industry association for Canadian MAiD clinicians
This page is a factual profile of the Canadian Association of MAiD Assessors and Providers (CAMAP). It draws on CAMAP's own website, CAMAP's published clinical guidance documents, Health Canada's advice to the profession, and ethics-of-MAiD commentary published in Canadian academic and professional journals. Primary-source links appear throughout.
Naming note. The organisation spells its name "CAMAP" (Canadian Association of MAiD Assessors and Providers). This page is reachable as camap.html; an alias at canmap.html redirects here for users who typed the name with an N.
What CAMAP is
Founded 2016. CAMAP formed in the year federal Bill C-14 legalised medical assistance in dying (June 2016). CAMAP's own founding narrative describes the organisation growing from
"a small email group of eight colleagues in British Columbia" (
camapcanada.ca).
Stated mission. CAMAP describes its purpose as to
"support MAiD professionals in their work" and to
"educate the health care community about MAiD", with the vision of being
"the Canadian leader for the community of professionals involved in medical assistance in dying". Source text:
camapcanada.ca.
Not a regulator. CAMAP is a professional association, not a statutory or regulatory body. Provincial colleges of physicians and surgeons remain the disciplinary authorities for MAiD clinicians; CAMAP produces guidance that its members may choose to follow.
CAMAP's published clinical guidance
CAMAP publishes clinical-practice guidance documents directed at clinicians who assess and provide MAiD. Three are cited most frequently in the public record and in regulator-level materials:
Clinical guidance · 2022
"Bringing up MAiD as a Care Option"
Published: February 2022. Audience: physicians, nurse practitioners, nurses, and allied health professionals.
Core instruction, quoted from the document: the guidance tells clinicians that in certain circumstances it is appropriate for the clinician to raise medical assistance in dying as a clinical care option with a patient who has not asked about it, alongside other end-of-life options. The guidance itself acknowledges the ethical tension, stating (quoted):
"There is no risk-free method to bring up MAiD."
Primary source (PDF): camapcanada.ca/wp-content/uploads/2022/02/Bringing-up-MAiD.pdf
Clinical guidance · interpretation of the statute
"The Interpretation and Role of 'Reasonably Foreseeable' in MAiD Practice"
CAMAP guidance document on how clinicians should apply the Criminal Code s. 241.2 eligibility criterion of a reasonably foreseeable natural death — the hinge between Track 1 (death foreseeable) and Track 2 (death not foreseeable) eligibility.
Primary source: listed on camapcanada.ca resources.
Clinical guidance · pharmacology
"Intravenous MAiD Medication Protocols in Canada"
CAMAP-published protocol describing the intravenous drug regimens used by clinician-providers. Published on the CAMAP resources page (camapcanada.ca).
The "Bringing up MAiD" debate on the public record
The 2022 CAMAP guidance has drawn sustained ethical criticism from bioethicists and clinicians. The criticism is about the asymmetry of the doctor-patient power relationship, not about the legality of the act. The section below quotes the public record.
Kerry Bowman, University of Toronto Joint Centre for Bioethics, published commentary (2022): "Some people, no matter how well-handled your conversation, may infer that it's essentially a suggestion" and
"they would also definitely infer that they have the strong potential to meet eligibility criteria, or you wouldn't be offering it." (Quoted in Dying With Dignity Canada conference proceedings, January 2022 —
dyingwithdignity.ca.)
Health Canada, Advice to the Profession: Health Canada publishes federal-level clinical guidance at
canada.ca/.../advice-profession.pdf. The federal advice addresses how practitioners can raise MAiD in a clinical conversation and references CAMAP's guidance as an educational resource. It does not impose raising MAiD as a duty of the clinician.
Power-dynamic concern. The core ethical concern raised in commentary is that a clinician who volunteers MAiD as an option — absent a patient-initiated request — transmits an implicit professional judgement to the patient: that the clinician considers the patient close enough to eligibility to mention the option. In an asymmetric doctor-patient relationship, this may be heard as a recommendation by the patient.
What the CAMAP guidance itself says about this. The guidance acknowledges the concern, and tells clinicians that "a respectful, trusting patient-clinician relationship and enough time for such sensitive conversations" are preconditions for raising MAiD. The document does not resolve the power-asymmetry concern; it treats it as a clinical-skill matter.
Why CAMAP matters for the accountability record
CAMAP's guidance influences practice. CAMAP guidance is cited in provincial college policy, in Health Canada's federal advice to the profession, and in provincial/territorial ministry of health MAiD resources. Clinicians who follow CAMAP's 2022 "Bringing up MAiD" guidance will, in some circumstances, raise the option unprompted. This is a material change in clinical practice compared with the pre-2022 norm, and it is not visible to patients as a policy change.
The Track 2 expansion context. MAiD eligibility was extended in 2021 (Bill C-7) to persons whose natural death is not reasonably foreseeable. CAMAP's "Reasonably Foreseeable" guidance is one of the key practitioner-level documents governing how clinicians assess this boundary. The boundary determines whether a patient can be offered Track 2 MAiD.
Governance asymmetry. Patients do not encounter CAMAP as a name, brand, or decision-maker. They encounter their own clinician. CAMAP's guidance shapes what that clinician says and offers. This is the public-record pattern: the entity that sets the practice norm is invisible to the patient; the patient sees only the outcome of that norm.
Open questions the public record does not yet answer
TENET5 lists these as open rather than as allegations. The questions are ordinary-course questions about any professional association whose guidance shapes clinical practice on an irreversible intervention.
Q1. What is the full list of CAMAP's sources of operating revenue? CAMAP's public website discloses donation options (one-time, monthly, legacy). It does not, on the public pages reviewed, disclose a breakdown of federal grants, provincial transfers, pharmaceutical or device-industry sponsorship, or private foundation support. (Source:
camapcanada.ca, public pages.)
Q2. How many Canadian clinicians are CAMAP members, and what percentage of all MAiD assessors and providers nationally does that represent?
Q3. To what extent have CAMAP-published documents been adopted by provincial colleges of physicians and surgeons as the operative standard of practice for MAiD in that province?
Q4. Does CAMAP guidance distinguish between Track 1 and Track 2 cases when instructing clinicians on raising MAiD unprompted — and if so, does the same "may raise the option" advice apply in Track 2 (non-terminal) cases, where the patient's underlying condition is disability, chronic illness, or mental suffering rather than an imminent death trajectory?
Primary sources cited on this page
Correction policy
This page states facts on the public record about CAMAP. It does not accuse CAMAP of illegality, and it does not accuse any individual CAMAP member of wrongdoing. If you are from CAMAP and anything on this page is factually inaccurate, the factual claim and its source are listed above; we will publish a correction with your supplied source on the same page, co-located with the original statement, if the corrected version is verifiable on the public record.